These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20414764)

  • 1. [Urinary tract immunology].
    Schubert S
    Urologe A; 2010 May; 49(5):606-11. PubMed ID: 20414764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The innate immune response during urinary tract infection and pyelonephritis.
    Spencer JD; Schwaderer AL; Becknell B; Watson J; Hains DS
    Pediatr Nephrol; 2014 Jul; 29(7):1139-49. PubMed ID: 23732397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive immune responses in the urinary tract.
    Song J; Abraham SN
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():21-8. PubMed ID: 18826478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintaining a sterile urinary tract: the role of antimicrobial peptides.
    Ali AS; Townes CL; Hall J; Pickard RS
    J Urol; 2009 Jul; 182(1):21-8. PubMed ID: 19447447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate and acquired immunity, cytokines, and genetic factors in relation to the mucosal immune system.
    Schenck K; Kiyono H
    Acta Odontol Scand; 2001 Jun; 59(3):121-3. PubMed ID: 11501879
    [No Abstract]   [Full Text] [Related]  

  • 6. The nature of immune responses to urinary tract infections.
    Abraham SN; Miao Y
    Nat Rev Immunol; 2015 Oct; 15(10):655-63. PubMed ID: 26388331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract.
    Zasloff M
    J Am Soc Nephrol; 2007 Nov; 18(11):2810-6. PubMed ID: 17942949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collectins in urinary tract and kidney diseases.
    Qin Y; Liu J; Liu J; Hu F
    Int Urol Nephrol; 2018 Apr; 50(4):695-703. PubMed ID: 29071557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.
    Ragnarsdóttir B; Fischer H; Godaly G; Grönberg-Hernandez J; Gustafsson M; Karpman D; Lundstedt AC; Lutay N; Rämisch S; Svensson ML; Wullt B; Yadav M; Svanborg C
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():12-20. PubMed ID: 18826477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts of molecular defence mechanisms operative during urinary tract infection.
    Weichhart T; Haidinger M; Hörl WH; Säemann MD
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucosal immunity with emphasis on urinary tract immunity and diabetes].
    Krejsek J; Kudlová M; Kolácková M; Novosad J
    Vnitr Lek; 2008 May; 54(5):478-81. PubMed ID: 18630631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.
    Hashizume-Takizawa T; Yamamoto M
    Microbiol Immunol; 2015 Dec; 59(12):716-23. PubMed ID: 26564803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urinary tract response to entry of pathogens.
    Uehling DT; Johnson DB; Hopkins WJ
    World J Urol; 1999 Dec; 17(6):351-8. PubMed ID: 10654365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection.
    Godaly G; Bergsten G; Hang L; Fischer H; Frendéus B; Lundstedt AC; Samuelsson M; Samuelsson P; Svanborg C
    J Leukoc Biol; 2001 Jun; 69(6):899-906. PubMed ID: 11404374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR-mediated immune responses in the urinary tract.
    Song J; Abraham SN
    Curr Opin Microbiol; 2008 Feb; 11(1):66-73. PubMed ID: 18243043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.
    Ashkar AA; Mossman KL; Coombes BK; Gyles CL; Mackenzie R
    PLoS Pathog; 2008 Dec; 4(12):e1000233. PubMed ID: 19057665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection.
    Andersen-Nissen E; Hawn TR; Smith KD; Nachman A; Lampano AE; Uematsu S; Akira S; Aderem A
    J Immunol; 2007 Apr; 178(8):4717-20. PubMed ID: 17404249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'innate' host response protects and damages the infected urinary tract.
    Svanborg C; Bergsten G; Fischer H; Frendéus B; Godaly G; Gustafsson E; Hang L; Hedlund M; Karpman D; Lundstedt AC; Samuelsson M; Samuelsson P; Svensson M; Wullt B
    Ann Med; 2001 Dec; 33(9):563-70. PubMed ID: 11817650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors.
    Sirard JC; Bayardo M; Didierlaurent A
    Eur J Immunol; 2006 Feb; 36(2):260-3. PubMed ID: 16453385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
    Hopkins WJ; Gendron-Fitzpatrick A; Balish E; Uehling DT
    Infect Immun; 1998 Jun; 66(6):2798-802. PubMed ID: 9596750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.